Enliven 制药 ELVN
$49.43 +$4.64 (+10.36%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $49.75 +0.65%
开盘$46.19
昨收$44.79
当日区间$44.55 – $49.66
成交量969.8K
市值$3.64B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$37.21M-30.2% YoY
净利润-$32.49M-28.2% YoY
摊薄每股收益-$0.49+0.0% YoY
自由现金流-$18.63M-8.3% YoY
经营现金流-$18.53M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-15.3%
资产收益率-15.0%
投入资本回报率-18.0%
流动比率64.07
负债/资产比率1.7%
现金及投资$895.16M
净现金（净负债）$895.16M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $37.21M | $27.82M | $119.66M | $34.29M | $25.10M |
| 销售及管理费用 | $8.21M | $7.14M | $33.80M | $13.04M | $6.87M |
| -管理费用 | $8.21M | $7.14M | $33.80M | $13.04M | $6.87M |
| 研发费用 | $29.00M | $20.69M | $85.86M | $21.25M | $18.23M |
| 营业利润 | -$37.21M | -$27.82M | -$119.66M | -$34.29M | -$25.10M |
| 非经营性利息净收入（支出） | $4.73M | $4.20M | $16.01M | $4.62M | $4.95M |
| 非经营性利息收入 | $4.73M | $4.20M | $16.01M | $4.62M | $4.95M |
| 其他收入（支出） | -$8,000.00 | – | -$49,000.00 | $0.00 | – |
| 其他非经营性收入（支出） | -$8,000.00 | – | -$49,000.00 | $0.00 | – |
| 税前利润 | -$32.49M | -$23.63M | -$103.69M | -$29.67M | -$20.15M |
| 净利润 | -$32.49M | -$23.63M | -$103.69M | -$29.67M | -$20.15M |
| 持续经营利润 | -$32.49M | -$23.63M | -$103.69M | -$29.67M | -$20.15M |
| 归属母公司净利润 | -$32.49M | -$23.63M | -$103.69M | -$29.67M | -$20.15M |
| 归属普通股股东净利润 | -$32.49M | -$23.63M | -$103.69M | -$29.67M | -$20.15M |
| 基本每股收益 | -$0.49 | -$0.38 | -$1.83 | -$0.48 | -$0.32 |
| 摊薄每股收益 | -$0.49 | -$0.38 | -$1.83 | -$0.48 | -$0.32 |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
| -减：重组及并购费用 | – | – | $0.00 | $0.00 | $0.00 |
| 税费 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $910.22M | $464.85M | $476.17M | $476.17M | $490.88M |
| 流动资产合计 | $907.34M | $463.14M | $474.88M | $474.88M | $482.68M |
| 现金及现金等价物与短期投资 | $895.16M | $452.40M | $462.62M | $462.62M | $477.57M |
| -现金及现金等价物 | $135.51M | $132.18M | $98.90M | $98.90M | $101.73M |
| -短期投资 | $759.65M | $320.22M | $363.73M | $363.73M | $375.83M |
| 其他流动资产 | $12.18M | $10.74M | $12.26M | $12.26M | $5.12M |
| 非流动资产合计 | $2.88M | $1.72M | $1.29M | $1.29M | $8.19M |
| 固定资产净值 | $1.64M | $310,000.00 | $417,000.00 | $417,000.00 | $874,000.00 |
| -固定资产原值 | $1.89M | $553,000.00 | $646,000.00 | $646,000.00 | $2.01M |
| -累计折旧 | -$250,000.00 | -$243,000.00 | -$229,000.00 | -$229,000.00 | -$1.14M |
| 一年以上递延资产 | $0.00 | $217,000.00 | $217,000.00 | $217,000.00 | $217,000.00 |
| 其他非流动资产 | $1.24M | $1.19M | $656,000.00 | $656,000.00 | $7.10M |
| 负债合计 | $15.07M | $11.49M | $16.57M | $16.57M | $14.75M |
| 流动负债合计 | $14.16M | $11.49M | $16.57M | $16.57M | $14.65M |
| 应付款 | $371,000.00 | $1.64M | $2.16M | $2.16M | $1.43M |
| -应付账款 | $371,000.00 | $1.64M | $2.16M | $2.16M | $1.43M |
| 一年内应计费用 | $10.03M | $7.18M | $9.36M | $9.36M | $8.79M |
| 短期债务及融资租赁负债 | $597,000.00 | $302,000.00 | $399,000.00 | $399,000.00 | $387,000.00 |
| -一年内到期融资租赁负债 | $597,000.00 | $302,000.00 | $399,000.00 | $399,000.00 | $387,000.00 |
| 其他流动负债 | $133,000.00 | $107,000.00 | $351,000.00 | $351,000.00 | $86,000.00 |
| 非流动负债合计 | $913,000.00 | $0.00 | $0.00 | $0.00 | $103,000.00 |
| 其他非流动负债 | $913,000.00 | – | – | – | $103,000.00 |
| 股东权益合计 | $895.15M | $453.37M | $459.60M | $459.60M | $476.12M |
| 股东权益 | $895.15M | $453.37M | $459.60M | $459.60M | $476.12M |
| 股本 | $73,000.00 | $61,000.00 | $59,000.00 | $59,000.00 | $59,000.00 |
| -普通股 | $73,000.00 | $61,000.00 | $59,000.00 | $59,000.00 | $59,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.30B | $824.48M | $806.37M | $806.37M | $793.34M |
| 留存收益 | -$403.28M | -$370.79M | -$347.17M | -$347.17M | -$317.50M |
| 不影响留存收益的损益 | -$1.91M | -$382,000.00 | $334,000.00 | $334,000.00 | $221,000.00 |
| 受限现金 | – | – | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$18.53M | -$19.29M | -$70.30M | -$15.84M | -$13.28M |
| 持续经营经营活动现金流净额 | -$18.53M | -$19.29M | -$70.30M | -$15.84M | -$13.28M |
| 持续经营净利润 | -$32.49M | -$23.63M | -$103.69M | -$29.67M | -$20.15M |
| 折旧、折耗与摊销 | $7,000.00 | $14,000.00 | $263,000.00 | $46,000.00 | $62,000.00 |
| 其他非现金项目 | $126,000.00 | $93,000.00 | $353,000.00 | $92,000.00 | $89,000.00 |
| 营运资金变动 | -$605,000.00 | -$3.43M | -$1.12M | $1.22M | -$157,000.00 |
| -预付资产变动 | -$2.16M | $1.65M | -$1.11M | -$694,000.00 | $139,000.00 |
| -应付账款及应计费用变动 | $1.68M | -$4.98M | $321,000.00 | $2.00M | -$206,000.00 |
| -其他流动负债变动 | -$129,000.00 | -$97,000.00 | -$337,000.00 | -$91,000.00 | -$90,000.00 |
| 投资活动现金流净额 | -$441.57M | $42.53M | -$173.84M | $12.38M | -$4.06M |
| 持续经营投资活动现金流净额 | -$441.57M | $42.53M | -$173.84M | $12.38M | -$4.06M |
| 固定资产购置及出售净额 | -$99,000.00 | $0.00 | $55,000.00 | $213,000.00 | $1,000.00 |
| 投资购置及出售净额 | -$441.47M | $42.53M | -$173.90M | $12.17M | -$4.06M |
| 筹资活动现金流 | $463.42M | $10.05M | $218.87M | $623,000.00 | -$368,000.00 |
| 持续经营筹资活动现金流净额 | $463.42M | $10.05M | $218.87M | $623,000.00 | -$368,000.00 |
| 股票期权行使所得 | $29.94M | $10.05M | $2.92M | $721,000.00 | $209,000.00 |
| 期末现金余额 | $135.51M | $132.18M | $98.90M | $98.90M | $101.73M |
| 现金净变动 | $3.32M | $33.29M | -$25.28M | -$2.84M | -$17.71M |
| 期初现金余额 | $132.18M | $98.90M | $124.17M | $101.73M | $119.44M |
| 自由现金流 | -$18.63M | -$19.29M | -$70.46M | -$15.84M | -$13.28M |
| 持续经营损益 | – | – | $106,000.00 | – | – |
| 普通股发行净额 | – | – | $216.17M | $0.00 | -$458,000.00 |
| 其他筹资费用净额 | – | – | -$217,000.00 | -$98,000.00 | – |
暂无评论——快来第一个聊聊 ELVN。
登录后参与讨论。